Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized double-blind trial of group A and group C meningococcal polysaccharide conjugate vaccine in healthy participants aged 3 months to 23 months
CTR20181556Phase 3Active
- Sponsor
- Hualan Biological Vaccine
- Start
- Jul 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of meningococcal group A and C conjugate vaccine in meningococcal disease, meningococcal meningitis, sponsored by Hualan Biological Vaccine. Started Jul 2018; status: active.
02
Drugs
meningococcal group A and C conjugate vaccine
03
Conditions
meningococcal diseasemeningococcal meningitis
Beyond the preview
Go deeper on CTR20181556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20181556.